4BASEBIO UK SOCIETAS
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally. The company offers hpDNA, double stranded linear DNA, covalently closed with single strand hairpins at the 5' and 3' ends for viral and non-viral vector applicat… Read more
4BASEBIO UK SOCIETAS - Asset Resilience Ratio
4BASEBIO UK SOCIETAS (4BB) has an Asset Resilience Ratio of 0.50% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how 4BASEBIO UK SOCIETAS's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down 4BASEBIO UK SOCIETAS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX225.00K | 0.5% |
| Total Liquid Assets | GBX225.00K | 0.50% |
Asset Resilience Insights
- Limited Liquidity: 4BASEBIO UK SOCIETAS maintains only 0.50% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
4BASEBIO UK SOCIETAS Industry Peers by Asset Resilience Ratio
Compare 4BASEBIO UK SOCIETAS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for 4BASEBIO UK SOCIETAS (2019–2024)
The table below shows the annual Asset Resilience Ratio data for 4BASEBIO UK SOCIETAS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.50% | GBX225.00K | GBX44.73 Million | -1.48pp |
| 2023-12-31 | 1.98% | GBX236.00K | GBX11.92 Million | -0.07pp |
| 2022-12-31 | 2.05% | GBX240.00K | GBX11.69 Million | +0.50pp |
| 2021-12-31 | 1.55% | GBX228.00K | GBX14.70 Million | +0.32pp |
| 2020-12-31 | 1.23% | GBX219.00K | GBX17.81 Million | -15.74pp |
| 2019-12-31 | 16.97% | GBX196.00K | GBX1.16 Million | -- |